X4 Pharmaceuticals Inc (XFOR) support and resistance · rev $4.8M
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
This page maps X4 Pharmaceuticals Inc (XFOR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
XFOR currently screens at market cap $382.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new XFOR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the XFOR quote page for the session range and the stock page for the full model.
Not investment advice.